- 中文名称
EZScreen™游离脂肪酸比色测定试剂盒（384孔）
- 英文名字
- EZScreen™ Free Fatty Acid Colorimetric Assay Kit (384-well)
- 供应商
- Biovision
- 产品货号
- K956-400
- 产品报价
- ￥询价/400assays
- 产品说明书
- 点击查看
- 购买方式
- 银行转账、电汇、支票、现金，在线支付宝及网银支付，或直接与我们电话联系400-6800-868.
- 产品新闻
- 背景资料
- 待更新
- 产品描述
- Fatty Acids play important roles in normal metabolism and in many disease states. They are precursors to a number of bioactive classes of compounds including prostaglandins and leukotrienes, and have been implicated to play roles in such diverse functions as the immune system, autism, and the inflammatory response. Fatty acid levels are an important measure of the physiologic state. High levels are associated with diabetes mellitus, obesity, endocrine dysfunctions, and metabolic syndrome. BioVision’s EZScreenTM Free Fatty Acid Colorimetric assay kit provides a simple method for the quantification free fatty acids. The kit offers a convenient, sensitive, enzyme-based method for the detection of long-chain (C-8 (octanoate) and longer) fatty acids in various biological samples. In the EZScreenTM assay, fatty acids are converted to their CoA derivatives, which are subsequently oxidized by the enzyme mix to yield an intermediate. Formed intermediate then reacts with the Free Fatty acid probe to generate color which can be read by a spectrophotometer at OD 570 nm. Our 384-well format enables analyses of large number of samples on a single plate in a high throughput mode. Sample volumes between 1 and 10 μl can be used with this kit
- 产品特点
- • Simple procedure; takes ~40 minutes
• Fast and convenient
• Kit contains all necessary reagents for rapid, sensitive and accurate measurement of Adipolysis in cell culture samples
- 保存建议
- -20
- 其他
- BioVision的公司总部在美丽的旧金山湾地区，它是全球生命科学公司的领导者.BioVision在开发和研究细胞凋亡检测分析、代谢检测方面具有卓越的影响力.包括检测各种检测分析试剂盒、相关特色抗体、重组蛋白及细胞因子和酶等多种产品，以及其他创新的研究工具.其产品覆盖细胞凋亡研究、能量代谢、细胞/组织蛋白提取、氧化应激与损伤、代谢与肥胖症、细胞增殖与毒性、信号转导、干细胞研究等领域.作为多家知名品牌的中国总代理以及中国区域代理，艾美捷与BioVision一起为研究者们提供最好、最新的细胞生物学研究工具而不断扩大产品及服务质量.
-
- 注意
-
该页面的中文产品信息的翻译，仅供参考。准确的产品信息请以厂家的英文说明书为准。下单前，请浏览说明书确认。
-
